Business News • MarketWire • Radient Pharmaceuticals Accelerating Distributor Partnerships for Its Onko-Sure In Vitro Diagnostic Cancer Test in India via Government and Distributor Meetings

Radient Pharmaceuticals Accelerating Distributor Partnerships for Its Onko-Sure In Vitro Diagnostic Cancer Test in India via Government and Distributor Meetings

Radient Pharmaceuticals Accelerating Distributor Partnerships for Its Onko-Sure In Vitro Diagnostic Cancer Test in India via Government and Distributor Meetings

TUSTIN, CA--(Marketwire - May 14, 2010) - Through its US-based subsidiary AMDL Diagnostics Inc., Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today its executive management will be in India May 20, 2010 through May 25, 2010 with the goal of accelerating the commercialization of RPC's Onko-SureT in vitro diagnostic (IVD) cancer test in India through distribution partnerships with Gaur Diagno (New Delhi).

View More : http://www.marketwire.com/mw/release.do?id=1260351&sourceType=3

Releted News by marketwire

Imperial Capital Advises Western Money Systems in Its Sale to Global Cash Access Holdings

CNBCpicks Report: Paradigm Oil, Cisco Systems, Sybase Inc., Bank of America, Citigroup, Sirius XM, Ford Motors

Proxim Wireless Reports First Quarter 2010 Financial Results

Venture Capital Industry Saw Short Term Performance Improvements at the End of 2009